300803:SZSEBeijing Compass Technology Development Co. Ltd. Class A Analysis
Data as of 2026-07-11 - not real-time
CN¥81.31
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Beijing Compass is trading at CNY 81.31, just above the computed support of CNY 78.97, but well below its 20‑day (CNY 92.08) and 50‑day (CNY 94.35) simple moving averages, indicating a bearish price momentum. The MACD histogram is negative and the RSI sits at 39, reinforcing short‑term downside pressure, while volume trends are decreasing and 30‑day volatility is elevated at roughly 73%, suggesting heightened price swings. On the fundamentals side, revenue jumped 31% year‑over‑year and gross margins remain robust at 91%, yet earnings are thin with a profit margin of 8.6% and a trailing PE of 254× versus an industry average of 35×, making the stock appear dramatically overvalued on earnings metrics. The company holds an abundant cash pile of CNY 14.9 bn against CNY 2.76 bn of debt, supporting a modest dividend yield of 0.1% and a low payout ratio of 25%, but the high forward PE of 90× and a max drawdown of –55% underline valuation and price‑risk concerns.
The DCF model suggests a fair value near CNY 290, implying a potential upside if earnings improve, while the strong cash generation (CNY 4.6 bn free cash flow) provides a cushion for future growth initiatives. However, the firm operates in China’s software‑application sector, which faces heightened regulatory scrutiny, adding a layer of geopolitical risk. Balancing the bullish growth drivers against the bearish technicals and valuation gaps leads to a nuanced stance: short‑term caution, medium‑term neutrality, and a tentative long‑term upside if the company can translate its revenue growth into sustainable profitability.
The DCF model suggests a fair value near CNY 290, implying a potential upside if earnings improve, while the strong cash generation (CNY 4.6 bn free cash flow) provides a cushion for future growth initiatives. However, the firm operates in China’s software‑application sector, which faces heightened regulatory scrutiny, adding a layer of geopolitical risk. Balancing the bullish growth drivers against the bearish technicals and valuation gaps leads to a nuanced stance: short‑term caution, medium‑term neutrality, and a tentative long‑term upside if the company can translate its revenue growth into sustainable profitability.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Price below short‑term moving averages
- Bearish MACD and RSI indicating momentum weakness
- Decreasing volume and high short‑term volatility
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Strong 31% revenue growth
- Robust cash position offsetting high debt ratio
- Elevated valuation multiples (PE 254×) limiting upside
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- DCF‑derived fair value far above current price
- Sustainable dividend with low payout ratio
- Potential for earnings improvement as cash fuels growth initiatives
Key Metrics & Analysis
Financial Health
Revenue Growth31.00%
Profit Margin8.61%
P/E Ratio254.1
ROE7.82%
ROA0.32%
Debt/Equity96.86
P/B Ratio17.3
Op. Cash FlowCN¥4.6B
Free Cash FlowCN¥4.6B
Industry P/E34.7
Technical Analysis
TrendBearish
RSI39.7
SupportCN¥78.97
ResistanceCN¥107.80
MA 20CN¥92.08
MA 50CN¥94.35
MA 200CN¥118.46
MACDBearish
VolumeDecreasing
Fear & Greed Index94.59
Valuation
Fair ValueCN¥290.20
GradeOvervalued
TypeGrowth
Dividend Yield0.10%
Risk Assessment
Beta0.60
Volatility72.82%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.